Respiratory drug sales peak in November amid worsening AQI

›
India's air quality decline is boosting medicines for breathing problems. The respiratory drug market grew 8% last month, a rise from pr...

Dr Reddy’s inks licensing deal to sell Immutep’s cancer drug

›
Dr. Reddy's Laboratories has secured an exclusive licensing agreement with Immutep to manufacture, develop, and distribute the Australia...

ET Exclusive | Biologics merger with Biocon most value-accretive option: Kiran Mazumdar Shaw

›
Biocon is fully integrating Biocon Biologics, valuing its biosimilar business at $5.5 billion. This move removes debt concerns and improves ...

Biocon to make Biocon Biologics a wholly owned subsidiary

›
Biocon is set to fully integrate its biosimilar arm, Biocon Biologics. This move will make Biocon Biologics a wholly owned subsidiary. Bioco...

Abbott asks stockists to buy only from authorised suppliers

›
Spurious medicines were seized in Puducherry, prompting drug maker Abbott Healthcare to warn stockists. They must buy only from authorized s...

Lupin gets USFDA nod for multiple sclerosis drug

›
Drug maker Lupin has secured approval from the US health regulator for its generic multiple sclerosis treatment. The company received tentat...

AI and technology tackling India’s growing stroke crisis: Early detection and prevention take centre stage

›
India faces a mounting crisis with a 51% rise in stroke cases over the last 30 years, recording 1.25 million new strokes in 2021 alone. Yet ...